Presence of monosomal karyotype a predictor for poor survival in acute myeloid leukemia

October 2008
Hem/Onc Today;10/25/2008, Vol. 9 Issue 19, p34
The article discusses the results of a trial on the link between monosomal karyotype and acute myeloid leukemia (AML). According to the results of the trial involving 733 patients published in a 2008 issue of the "Journal of Clinical Oncology," the presence of monosomal karyotype is a sign of poor survival and prognosis in patients with AML.


Related Articles

  • Risk stratification using a new prognostic score for patients with secondary acute myeloid leukemia: results of the prospective AML96 trial. Stölzel, F.; Pfirrmann, M.; Aulitzky, W. E.; Kaufmann, M.; Bodenstein, H.; Bornhäuser, M.; Röllig, C.; Kramer, M.; Mohr, B.; Oelschlägel, U.; Schmitz, N.; Soucek, S.; Thiede, C.; Ehninger, G.; Schaich, M. // Leukemia (08876924);Mar2011, Vol. 25 Issue 3, p420 

    Patients with secondary acute myeloid leukemia (sAML) are generally thought to have a poor prognosis. As there are no prognostic risk stratification models for patients with sAML available, the aim of this study was to obtain a scoring system. Prognostic factors influencing overall survival (OS)...

  • Population-based demographic study of karyotypes in 1709 patients with adult Acute Myeloid Leukemia. Sanderson, R. N.; Johnson, P. R. E.; Moorman, A. V.; Roman, E.; Willett, E.; Taylor, P. R.; Proctor, S. J.; Bown, N.; Ogston, S.; Bowen, D. T. // Leukemia (08876924);Mar2006, Vol. 20 Issue 3, p444 

    Few large demographic studies of acute myeloid leukemia (AML) are derived from population-based registries. Demographic and karyotypic data were provided for AML cases from two regional leukemia registry databases in Scotland and the Northern Region of England. A population-based dataset was...

  • Early clearance of peripheral blasts measured by flow cytometry during the first week of AML induction therapy as a new independent prognostic factor: a GOELAMS study. Lacombe, F.; Arnoulet, C.; Maynadié, M.; Lippert, E.; Luquet, I.; Pigneux, A.; Vey, N.; Casasnovas, O.; Witz, F.; Béné, M. C. // Leukemia (08876924);Feb2009, Vol. 23 Issue 2, p350 

    An early appreciation of treatment efficacy could be very useful in acute myeloblastic leukemia (AML), and a prognostic value has been suggested for the morphological assessment of decrease in blasts during induction therapy. More sensitive, multiparametric flow cytometry (FCM) can detect far...

  • Normal Karyotype in a Case of Acute Myeloid Leukemia With Monocytic Differentiation and Hemophagocytosis by Leukemic Blasts. Salazar, Katrina L.; Mosse, Claudio // Laboratory Medicine;Winter2015, Vol. 46 Issue 1, p64 

    We report the case of a 39-year-old woman with acute myeloid leukemia (AML) with monocytic differentiation showing hemophagocytosis by leukemic blasts. This phenomenon is known to be associated with certain chromosomal changes, including t(8;16), der(8), inv(8), and t(16;21); however, in this...

  • Acute Promyelocytic Leukemia. Adams, Julia; Nassiri, Mehdi // Archives of Pathology & Laboratory Medicine;Oct2015, Vol. 139 Issue 10, p1308 

    The majority of patients with acute promyelocytic leukemia (APL) manifest the t(15;17)(q24.1;q21.2) translocation; however, a minor but significant proportion of patients with APL harbor complex, cryptic, or variant translocations, which typically involve RARA. With the exception of ZBTB16/RARA,...

  • Klinický význam génových mutácií u akútnych myeloidných leukémií s normálnym karyotypom. Katrincsáková, B.; Szotkowski, T.; Divoká, M.; Indrák, K.; Jarošová, M. // Transfusiology & Haematology Today / Transfuze a Hematologie Dne;Jun2011, Vol. 17 Issue 2, p72 

    Acute myeloid leukemia (AML) is characterized by distinct clinical and genetic heterogeneity. Chromosomal aberrations are present in about 55% of patients at the time of diagnosis however a large group of AML (about 45%) comprise patients with normal karyotype (NK-AML). In the latter group, gene...

  • Cytogenetic Profile of de novo Acute Myeloid Leukemia Patients in Malaysia. Chin Yuet Meng; Noor, Puteri J.; Ismail, Azli; Md Ahid, Mohd Fadly; Zakaria, Zubaidah // International Journal of Biomedical Science;Mar2013, Vol. 9 Issue 1, p26 

    Acute myeloid leukemia (AML) is a heterogeneous disease in terms of cytogenetics and molecular genetics. AML is the most common acute leukemia in adults and its incidence increases with age. Diagnostic cytogenetics is an important prognostic indicator for predicting outcome of AML. We examined...

  • Core-Binding Factor Acute Myeloid Leukemia. Sangle, Nikhil A.; Perkins, Sherrie L. // Archives of Pathology & Laboratory Medicine;Nov2011, Vol. 135 Issue 11, p1504 

    Core-binding factor acute myeloid leukemia (AML) is cytogenetically defined by the presence of t(8;21) (q22;q22) or inv(16)(p13q22)/t(16;16)(p13;q22), commonly abbreviated as t(8;21) and inv(16), respectively. In both subtypes, the cytogenetic rearrangements disrupt genes that encode subunits of...

  • Prognostic significance of CD56 antigen expression in patients with acute myeloid leukemia. Djunic, Irena; Virijevic, Marijana; Djurasinovic, Vladislava; Novkovic, Aleksandra; Colovic, Natasa; Kraguljac-Kurtovic, Nada; Vidovic, Ana; Suvajdzic-Vukovic, Nada; Tomin, Dragica // Medical Oncology;Sep2012, Vol. 29 Issue 3, p2077 

    The aims of this study were to investigate the frequency and prognostic relevance of CD56 expression in patients with acute myeloid leukemia (AML) and to compare the importance of CD56 expression with standard prognostic factors, such as age, leukocytosis, cytogenetic abnormalities and...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics